Innovatiview, India’s largest leading examination technology and
infrastructure companies, today announced the appointment of Priyank Kanade as Chief Business
Officer, Examination Infrastructure Business. Priyank will lead Innovatiview’s Examination
Infrastructure Business under the brand name of Aadarsh Pariksha Kendra with a mandate to drive
expansion of the company’s CBT (Computer Based Test) exam centre network across India.
Priyank brings over 15 years of leadership experience across consumer technology, D2C e-
commerce, omni-channel retail, and management consulting. Over the course of his career, he has
held leadership positions at renowned organisations including CaratLane (a Tata Group company),
Flipkart, Livspace, Furlenco, and Accenture, where he led large-scale business operations, strategic
growth initiatives, and operational transformation programs.
He holds an MBA from the Indian School of Business (ISB), Hyderabad and a B.Tech in Chemical
Engineering from IIT Bombay.
Commenting on the appointment, Mr. Ashish Mittal, Whole-time Director, Innovatiview, said:
“Priyank brings a rare combination of strategic thinking, operational excellence, and the ability to build
businesses at scale. As India’s examination ecosystem undergoes rapid and structural transformation,
his leadership will play a critical role in strengthening Innovatiview’s position as a trusted partner for
secure, technology-driven assessment infrastructure across the country.”
Speaking on his appointment, Priyank Kanade said: “India still has a long way to go in providing fair,
tech-enabled testing infrastructure for everyone. In a country where an exam defines entire career for
millions of students, so getting to build reliable, large-scale systems that truly protect that future is
incredibly meaningful to me. I’m really excited to join Innovatiview just as they are scaling up to meet
this challenge.”
Innovatiview is a technology-driven company providing ancillary security, surveillance, and
infrastructure solutions for examinations across India. As of September 30, 2024, the company is
India’s largest integrated examination security player, commanding a 73.7% revenue market share in
Fiscal 2024 (Source: F&S Report).
The company offers end-to-end examination security to curb malpractices, utilizing CCTV
surveillance, biometric controls, physical frisking, VoIP communication, GPS tracking, and dedicated
infrastructure. Innovatiview is India’s first company, for integrating AI technology into CCTV
surveillance and touchless biometric verification to prevent impersonation. In the six months ending
September 30, 2024, it served over 72 clients and secured more than 1,409 examinations nationwide.
Innovatiview has continually been expanding its reach into the field of test administration and testing
infrastructure, providing solutions to government departments, educational organizations, and
recruitment companies alike.
Disclaimer:
Innovatiview India Limited is proposing, subject to, receipt of requisite approvals, market conditions
and other considerations, to make an initial public issuance of its Equity Shares and has filed the
DRHP dated February 13, 2025 with SEBI and the Stock Exchanges on February 14, 2025. The
DRHP shall be available on the website of the Company at www.innovatiview.com, SEBI at
www.sebi.gov.in, as well as on the websites of the BRLMs, i.e. DAM Capital Advisors Limited, ICICI
Securities Limited, JM Financial Limited, Motilal Oswal Investment Advisors Limited and Shannon
Advisors Private Limited at www.damcapital.in, www.icicisecurities.com, www.jmfl.com,
www.motilaloswalgroup.com and www.shannon.co.in, respectively and the websites of National Stock
Exchange of India Limited and BSE Limited at www.nseindia.com and www.bseindia.com,
respectively. Any potential investor should note that investment in equity shares involves a high
degree of risk and for details relating to such risk, please see “Risk Factors” of the RHP, when
available. Potential investors should not rely on the DRHP for making any investment decision.
Specific attention of the investors is invited to “Risk Factors” beginning on page 44 of the DRHP. The
Equity Shares offered in the Offer have not been and will not be registered under the U.S. Securities
Act of 1933, as amended (“U.S. Securities Act”), or any state securities laws in the United States, and
unless so registered may not be offered or sold within the United States, except pursuant to an
exemption from, or in a transaction not subject to, the registration requirements of the U.S. Securities
Act and applicable state securities laws. Accordingly, such Equity Shares are being offered and sold
(i) outside of the United States in offshore transactions in reliance on Regulation S under the U.S.
Securities Act and the applicable laws of the jurisdiction where those offers and sales occur; and (ii)
within the United States to “qualified institutional buyers” (as defined in Rule 144A under the U.S.
Securities Act), pursuant to the private placement exemption set out in Section 4(a) of the U.S.
Securities Act.
